Hypercoagulability in critically ill patients with COVID 19, an observational prospective study.

Laure CalvetFrançois ThouyOlivier MascleAnne-Françoise SapinKévin GrapinJean Mathias LiteaudonBertrand EvrardBenjamin BonnetMireille AddaBertrand SouweineClaire Dupuis

Published in: PloS one (2022)

Our study confirmed that most COVID-19 ICU patients have hypercoagulability on admission and almost all on day 4. Hyperfibrinogenemia or fibrinolysis shutdown on day 4 were associated with unfavorable outcome.

Keyphrases

end stage renal disease
coronavirus disease
newly diagnosed
chronic kidney disease
emergency department
intensive care unit
prognostic factors
patient reported outcomes
mechanical ventilation
acute respiratory distress syndrome
extracorporeal membrane oxygenation